News & Analysis on Clinical Trial Services & Contract Research And Development
German packaging company Gerresheimer has announced plans to take over the pharmaceutical business of troubled Glass Group Inc (GGI) of the US, after a Delaware bankruptcy court approved the transaction.
Galapagos has announced that its acquisition of BioFocus' would accelerate its transition to a fully integrated drug development biopharmaceutical company after the two companies reached agreement on the terms of a recommended all share offer.
A newly discovered compound, which has revealed new links between cell signalling pathways and cell migration, may suggest new avenues for novel pharmaceutical therapies for treating a variety of diseases, including cancer.
Researchers in the US have uncovered a contributing factor in interferon resistance of malignant melanoma cells. The finding represents a step forward in understanding of this type of cancer and the changes in gene and cellular signalling that trigger...
The US Food and Drug Administration (FDA) has found itself once again without a permanent Commissioner after the current incumbent - Lester Crawford - resigned after 18 months in the post.
Danish pharmaceutical company Novo Nordisk has filed a lawsuit against France's Sanofi-Aventis, alleging that the latter has infringed patent protection for an insulin injection system for diabetes patients.
Genentech has announced that studies of Avastin in platinum-refractory ovarian cancer patients have been discontinued due to patients developing a serious bowel problem.
Researchers have claimed that a new microchip could cut animal testing in the pharmaceutical industry as well as speed up drug development. By increasing the efficiency of preclinical testing of new drugs the new chip is also set to save on costs.